Bright Minds Biosciences Inc. (DRUG)
Bright Minds Biosciences Inc., a biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States.
$73.50-0.02%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago+118.6%
The outlook
Bright Minds Biosciences Inc. currently reads as neutral based on mixed vs its moving averages, 45% of the way from its 52-week low to high, avg target +128% vs current price. This is a snapshot of current market data, not a forecast.
What’s behind the score
Price trendMixed vs its moving averages
52-week range45% of the way from its 52-week low to high
Price targetAvg target +128% vs current price
Analyst price target
~12-month · 3 analysts$167.57average target+128.0% vs now
Now $73.50
Low $143.01High $215.94
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$721.2M
52-wk high
$123.75
52-wk low
$31.98
50-day avg
$71.96
200-day avg
$75.67
Trailing P/E
—